Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Glucagon-like peptide-1 receptor agonist versus sodium-glucose cotransporter-2 inhibitor persistence in Medicare Advantage beneficiaries with type 2 diabetes, cardiovascular risk, and obesity.
Journal: Diabetes, obesity & metabolism
Published: August 20, 2025
Health care resource utilization and costs in Medicare Advantage beneficiaries using glucagon-like peptide-1 receptor agonists vs sodium-glucose cotransporter-2 inhibitors.
Journal: Journal of managed care & specialty pharmacy
Published: June 27, 2025
Lessons from the leucovorin shortages between 2009 and 2012 in a medicare advantage population: where do we go from here?
Journal: American health & drug benefits
Published: April 04, 2014
Showing 1-3 of 3
Last Updated: 09/26/2026